Jellatech reposted this
🌟 Big News from Jellatech! 🌟 We’re excited to announce the opening of our new 9,000 sq ft facility in Morrisville, NC—a major step forward for our mission to create sustainable, bio-identical proteins for human health and longevity applications. This cutting-edge facility, planned for GLP certification by 2026, will be the heart of Jellatech's R&D and scaling operations as we work to bring groundbreaking, ethically produced proteins to market. With advanced bioreactors and specialized labs, this space empowers us to: 🧬 Scale production of our bio-identical collagen for pre-clinical use 🧫 Advance cell line development for precision and consistency 🤝 Collaborate with industry partners on next-gen biostimulatory and regenerative health solutions Here's to the future of sustainable biotech and the positive impact it can bring across human and planetary health! 🚀🚀 #Jellatech #Biotechnology #SustainableProtein #HumanHealth #Longevity #CollagenInnovation #R&D #Biomedical #SustainableBiotech #RegenerativeMedicine #LifeSciences #FutureOfHealthcare #Biomanufacturing #Innovation
Jellatech Expands Operations with New 9,000 Sq Ft Facility Morrisville, NC - November 5, 2024 Jellatech, a leading innovator in sustainable protein production, is thrilled to announce the successful occupation of its new 9,000 sq ft facility designed for ongoing research and development. This facility, which is planned for GLP (Good Laboratory Practice) certification by 2026, marks a significant milestone in Jellatech’s mission to revolutionize the biotechnology landscape. The new facility will be the foundation for scaling up Jellatech’s bio-identical collagen manufacturing capabilities, with a focus on validation and enabling customers to enter pre-clinical trials. These efforts are crucial for establishing the groundwork needed for broad market adoption of collagen-based applications across various sectors. Equipped with advanced bioreactors and specialized labs, the facility allows Jellatech to accelerate the development of high-value proteins, optimize cell line development, and meet stringent regulatory requirements in the biomedical and pharmaceutical industries. “Our new facility represents a leap forward in our ability to deliver high-quality, consistent, and ethically produced proteins for human health and longevity applications,” said Stephanie Michelsen, CEO of Jellatech. “This move not only significantly increases our production capacity but also reinforces our commitment to setting new standards in sustainability, innovation and cutting edge biotechnology.” The facility, located in Morrisville, NC, will also serve as a hub for partnerships with industry leaders, enabling collaborative research and development aimed at advancing the next generation of biostimulatory and regenerative healthcare solutions. About Jellatech: Jellatech is at the forefront of biotechnology, specializing in sustainable, bio-identical protein production. With a focus on ethical, scalable, and environmentally friendly processes, Jellatech provides innovative solutions for industries ranging from biomedical to food and beverage. For more information, visit www.jellatech.com or contact hello@jellatech.com. #Jellatech #BiotechInnovation #HumanCollagen #SustainableBiotech #ProteinProduction #NewFacility #RDBreakthroughs #PreClinicalTrials #FutureOfBiotech #CollagenRevolution #GLPStandards